Tedizolid Noninferior To Linezolid For Treatment Of Patients With Gram-Positive Ventilated Hospital-Acquired Bacterial Pneumonia And Ventilator-Associated Pneumonia In Clinical Trial
April 06, 2021
Healio (4/5, Stulpin) reports researchers found “in a randomized controlled trial” that “tedizolid was noninferior to linezolid for day 28 all-cause mortality in the treatment of” patients with “gram-positive ventilated hospital-acquired bacterial pneumon...